Scar Clinical Trial
Official title:
Botulinum Toxin to Improve Results in Epicanthoplasty
Medial epicanthal fold is a common skin fold in the inner part of the eye in more than 50% Asia population, giving the illusion of a shorter palpebral fissure length and a wider intercanthal distance. Currently, various epicanthoplasty techniques have been well described to correct epicanthus fold. However, hypertrophic scarring after epicanthoplasty remains a clinical challenge, which seems inevitable and may leading to unpleasing supratarsal crease, recurrence of medial epicanthus fold, even obvious scar formation. Botulinum toxin type A (BTX-A) is widely used for facial rejuvenation and many other medical indications. It is a potent neurotoxin that indirectly blocks neuromuscular transmission and leads to functional denervation of striated muscle for 2 to 6 months after injection. Recently, experimental study and clinical trails have revealed that BTX-A can inhibit the growth of fibroblasts derived from hypertrophic scars and influenced the expression of transforming growth factor-β1. Therefore, we hypothesized that BTX-A can improve hypertrophic scarring after epicanthoplasty through release orbicularis oculi muscle tension, inhibit fibroblast growth, and reduce collagen production. The main aim of this trail is to evaluate the efficiency of BTX-A injection on improving hypertrophic scaring after epicanthoplasty.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Completed |
NCT01706848 -
Celotres for Improvement in Wound Healing and Resulting Scar Consequences Following Suturing of a Wound
|
N/A | |
Recruiting |
NCT01177358 -
Botox in the Healing of Surgical Wounds of the Neck
|
Phase 2 | |
Terminated |
NCT01459666 -
Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer
|
Phase 4 | |
Completed |
NCT00970671 -
Treatment of Surgical Scars Using the Pulsed Dye Laser
|
N/A | |
Recruiting |
NCT03561376 -
Zinc Oxide Versus Petrolatum Following Skin Surgery
|
Early Phase 1 | |
Completed |
NCT05293652 -
Effect of Hydrocortisone Iontophoresis Versus Hydrocortisone Phonophoresis On Post Surgical Scar
|
N/A | |
Recruiting |
NCT03406143 -
Evaluation of the Effect of CGF in Promoting Mechanical-stretch Induced in Vivo Skin Regeneration
|
N/A | |
Completed |
NCT05527756 -
Evaluation of the Cosmetic Outcomes of Totally Endoscopic Cardiac Surgery
|
||
Completed |
NCT02886988 -
Early Postoperative Prevention and Treatment of Median Sternotomy Scars With Botulinum Toxin Type A Injection
|
Phase 2/Phase 3 | |
Completed |
NCT05618912 -
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
|
N/A | |
Recruiting |
NCT05408117 -
Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color
|
N/A | |
Completed |
NCT04169438 -
Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions
|
N/A | |
Terminated |
NCT02520557 -
An Exploratory Study of Genetic and Clinical Factors for Serious Skin Reactions Among Users of Eslicarbazepine Acetate
|
||
Not yet recruiting |
NCT04621994 -
Cesarean Wound Closure: Dermabond Versus Steri Strips
|
N/A | |
Withdrawn |
NCT03395678 -
Acne Scarring in Skin of Color: Laser vs Microneedling
|
N/A | |
Completed |
NCT02744950 -
Comparison of Scar Results and Time for Closures of Scalp Defects Via Pulley Sutures or Layered Repairs
|
N/A | |
Not yet recruiting |
NCT01005992 -
Fractional Photothermolysis for the Treatment of Burn Scars
|
Phase 1 | |
Completed |
NCT04870008 -
Aesthetic Outcome of Running Cuticular Suture Distance (2mm vs 5mm)
|
N/A | |
Recruiting |
NCT04506255 -
Silicone Taping for the Improvement of Abdominal Donor Site Scars
|
N/A |